SIRT7 and neoplasm: Proteins such as SIRT7 inhibitors and targeting ligands like SP94 were incorporated to improve drug sensitivity and tumor targeting, while polymeric and functionalized NP platforms enabled controlled, responsive drug release in the tumor microenvironment.